Crossmark

Gene promoter and exon DNA methylation changes in colon cancer development – mRNA expression and tumor mutation alterations

Crossref DOI link: https://doi.org/10.1186/s12885-018-4609-x

Published Online: 2018-06-27

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Molnár, Béla

Galamb, Orsolya

Péterfia, Bálint

Wichmann, Barnabás

Csabai, István

Bodor, András

Kalmár, Alexandra

Szigeti, Krisztina Andrea

Barták, Barbara Kinga

Nagy, Zsófia Brigitta

Valcz, Gábor

Patai, Árpád V.

Igaz, Péter

Tulassay, Zsolt
Funding

Funding for this research was provided by:

National Research, Development and Innovation Office (KMR-12-1-2012-0216, NVKP_16-1-2016-0004)

Novo Nordisk Foundation Interdisciplinary Synergy Programme (NNF15OC0016584)

Országos Tudományos Kutatási Alapprogramok (OTKA-K111743)
License Information

Text and Data Mining valid from 2018-06-27
More Information

Article History

Received: 15 November 2017

Accepted: 18 June 2018

First Online: 27 June 2018

Ethics approval and consent to participate

: The study was conducted according to the Helsinki declaration and approved by the local ethics committee and government authorities (Regional and Institutional Committee of Science and Research Ethics (TUKEB) Nr.: 69/2008, 202/2009 and 23,970/2011 Semmelweis University, Budapest, Hungary). All routine colonic biopsy samples from the patients were taken after written informed consent and ethical permission was obtained for participation in the study.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.